Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income Tax (Tables)

v3.22.1
Income Tax (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of deferred income taxes
    As of December 31,  
    2021   2020  
In respect of:          
Net operating loss carry forward   $ 14,391   $ 14,693  
Research and development expenses     1,280     823  
Valuation of financial instruments     (6 )   (10 )
Less – valuation allowance     (15,665 )   (15,506 )
Net deferred tax assets   $
-
  $
-
 

 

Schedule of valuation allowance
Balance at January 1, 2019   $ 10,923  
Additions     2,485  
Balance at December 31, 2019   $ 13,408  
Additions     2,098  
Balance at December 31, 2020   $ 15,506  
Additions     159  
Balance at December 31, 2021   $ 15,665